of the opportunity and because of the technical challenges involved.
Synthetic nitrogen fertilisers are essential to modern agriculture but their efficiency is deeply problematic. Roughly half of applied synthetic nitrogen is never absorbed by crops; instead, it is lost through volatilisation, leaching or microbial denitrification in the soil.
The environmental consequences are substantial. Nitrous oxide, which is 300 times more potent as a greenhouse gas than CO 2
, is released and nitrogen run-off is among the leading causes of aquatic eutrophication. Synthetic fertiliser production is also estimated to account for 5-6 % of global greenhouse gas emissions through the Haber-Bosch process.
Biological nitrogen fixation, the ability of certain bacteria to convert atmospheric nitrogen into a form plants can use, is as old as agriculture itself. Legume-rhisobium symbiosis has been understood for well over a century. The challenge has been extending this capability to the major row crops like corn, wheat and rice, which account for the bulk of global nitrogen fertiliser demand.
BioConsortia ' s Always-N product uses Paenibacillus-based microbes that colonise the root zone of corn( and, in development, wheat and other cereals), fixing atmospheric nitrogen throughout the growing season.
Greenhouse testing of plants in various soils
Critically, it continues to fix nitrogen even in the presence of applied synthetic fertilisers, where biological products often see their activity suppressed when soil nitrogen levels are elevated by conventional inputs.
Field trial data from more than 1,000 trials across five years, and across diverse geographies including the US, Brazil, New Zealand and Europe, has consistently demonstrated yield maintenance or improvement with meaningful reductions in applied synthetic nitrogen( Figure 1).
In Brazilian corn trials specifically, an 11 % yield increase was recorded at multiple locations. If reliably reproducible at scale, this result is commercially significant in one of the world ' s most competitive and demanding agricultural markets.
Beyond nitrogen
BioConsortia ' s pipeline includes bionematicides, biofungicides and biostimulants, each addressing a different constraint on crop productivity. For example, its Solvarix * bionematicide, based on root-colonising microbes that have been optimised to suppress nematode populations, has shown strong results in trials in both North America and Brazil, and is progressing toward commercial launch. Plantparasitic nematodes cause estimated crop losses of over $ 100 billion / year worldwide and the withdrawal of several synthetic nematicides under regulatory pressure in recent decades has left significant gaps in growers ' toolkits.
Biostimulants, products that improve crop nutrition efficiency, tolerance to abiotic stress or quality traits, have seen rapid regulatory clarification in both the EU and the US in recent years, providing a more defined pathway for product registration and commercial deployment. Microbial biostimulants that enhance phosphorus solubilisation, optimise root architecture or improve wateruse efficiency under drought conditions offer measurable benefits for growers operating in variable or challenging environments.
Regulatory landscape
The commercial trajectory of microbial agricultural technologies is shaped not only by science but also by the regulatory environment in which products must be developed and registered. This environment varies significantly by geography and product type. Navigating it effectively is a material competency for companies in this space.
Brazil ' s experience is instructive. A market that once imposed multi-year registration timelines for biological products has, both in response to demonstrated grower demand and through deliberate policy choice, moved to a compressed registration pathway. Brazil now ranks among the most dynamic biologicals markets, with adoption concentrated in the large-scale row crop sector that drives its agricultural export economy.
In Europe, the EU Fertilising Products Regulation of 2019 created a harmonised framework for biostimulants for the first time, while the Farm to Fork strategy has created both regulatory incentives and commercial momentum for reduced synthetic input use. In the US, the EPA regulatory treats targeted microbial gene edits equivalently to wild-type organisms where no foreign genetic material is introduced. This provides
34 SPECIALITY CHEMICALS MAGAZINE ESTABLISHED 1981